Search results

...15800324}}</ref> A small pilot study suggested possible benefit from the [[tyrosine kinase]] inhibitor [[erlotinib]] in patients with advanced cholangiocarcinoma.<ref

...protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells] G. Schuetz et al (2004) Journal of Cell Biology. V